Skip to main content
logo
Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
103.73
-0.88 (-0.84%)
At close: Jul 23, 2026, 4:00 PM EDT
103.61
-0.12 (-0.12%)
After-hours: Jul 23, 2026, 6:55 PM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
PYLARIFY Revenue
972.39M989.12M1.06B
PYLARIFY Revenue Growth
-1.69%-6.50%24.26%
Other Radiopharmaceutical Oncology Revenue
--384.00K
Other Radiopharmaceutical Oncology Revenue Growth
---87.73%
Total Radiopharmaceutical Oncology Revenue
972.39M989.12M1.06B
Total Radiopharmaceutical Oncology Revenue Growth
-1.69%-6.53%23.85%
DEFINITY Revenue
335.66M330.25M317.79M
DEFINITY Revenue Growth
1.64%3.92%13.59%
Neuraceq Revenue
-51.45M-
TechneLite Revenue
-86.80M95.49M
TechneLite Revenue Growth
--9.09%9.29%
Other Precision Diagnostics Revenue
-24.62M24.23M
Other Precision Diagnostics Revenue Growth
-1.59%5.44%
Total Precision Diagnostics Revenue
508.82M493.11M437.51M
Total Precision Diagnostics Revenue Growth
3.18%12.71%12.15%
Strategic Partnerships and Other Revenue
64.98M59.38M38.18M
Strategic Partnerships and Other Revenue Growth
9.42%55.52%-26.40%
Revenue (Other)
-1.31B-1.48B-1.50B
Revenue (Total)
1.55B1.54B1.53B
Revenue (Total) Growth
0.30%0.50%18.32%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Product Revenue
1.51B1.51B1.52B
Product Revenue Growth
0.19%-1.13%20.72%
License and Royalty Revenue
35.67M34.04M9.13M
License and Royalty Revenue Growth
4.81%272.88%-72.64%
Revenue (Total)
1.55B1.54B1.53B
Revenue (Total) Growth
0.30%0.50%18.32%